PRVA Stock Analysis: Buy, Sell, or Hold?
PRVA - Privia Health Group, Inc. Common Stock
$22.95
-0.29 (-1.25%)
▼
5d:
-0.48%
30d:
-2.34%
90d:
+2.5%
BUY
HIGH Confidence
Analysis Updated: May 15, 2026 12:00 AM ET
Earnings: May 07, 2026
0d
Smart Money Accumulation
PRVA is down 3.1% this week, but smart money is accumulating calls. Top strike: $25 2026-06-18 with 14 OI. Call ratio: 100% View Scanner →
Strength: 6.6/10
Get Alerted When PRVA Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
✅ BUY SIGNAL: PRVA shows strong fundamentals and good volume confirmation. Solid entry point despite fair pricing.
✅ BUY SIGNAL: PRVA shows strong fundamentals and good volume confirmation. Solid entry point despite fair pricing.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$35.70
Based on 9.7% avg growth
INTRINSIC VALUE TODAY
$22.17
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 20.7x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: PRVA is currently trading at $22.95, which is considered fair relative to its 30-day fair value range of $22.72 to $24.37. The stock's valuation (Forward PE: 21.1) is in line with its historical norms (20.7). At these levels, the market is pricing in 0.6% annual earnings growth.
Technical Outlook: Technically, PRVA is showing sideways momentum. Immediate support is located at $21.40, while resistance sits at $25.11.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $31.58 (+37.6%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, PRVA is showing sideways momentum. Immediate support is located at $21.40, while resistance sits at $25.11.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $31.58 (+37.6%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
FAIR
Historical Trading Range
$22.72 -
$24.37
Company Quality Score
55/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
75.7%
All Signals
- NEUTRAL: Price in fair range
- NEUTRAL: Mixed technical signals (40/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 37.6% below Wall St target ($31.58)
- BULLISH: Expecting earnings turnaround to 0.6% growth with 25.8% revenue growth
Trading Range Analysis
30-Day Trading Range
$22.72 -
$24.37
Current vs Trading Range
FAIR
Support & Resistance Levels
Support Level
$21.40
Resistance Level
$25.12
Current Trend
Sideways
Technical data as of
May 15, 2026
Fundamental Context
Forward P/E (Next Year Est.)
21.07
Wall Street Target
$31.58
(+37.6%)
Revenue Growth (YoY)
25.8%
Earnings Growth (YoY)
-33.3%
Profit Margin
1.0%
Valuation Premium vs History
+0.6% premium
PE vs Historical
21.1 vs 20.7
FAIR
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
+0.6%
(market-implied from PE analysis)
1-Year Target
$23.09
(+1%)
2-Year Target
$23.23
(+1%)
3-Year Target
$23.37
(+2%)
3-Yr Target (if PE normalizes)
(PE: 21→21)
PE COMPRESSION
$22.96
(0%)
Earnings growth offset by PE compression
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 22.1, Growth: 15.4%)
$36.97
(+61%)
Base:
(SPY PE: 21.1, Growth: 15.4%)
$35.30
(+54%)
Bear:
(PE: 17.9, Growth: 15.4%)
$30.00
(+31%)
📈
Valuation based on Current Earnings
Forward PE: 20.79 | Forward EPS (Implied): $1.10
Bull Case
$27.71
(+21%)
Analyst growth 15.0%, PE expands to 21.8
Base Case
$22.95
(0%)
Market implied 0.0%, PE stable at 20.8
Bear Case
$17.56
(-24%)
Severe decline -15.0%, PE contracts to 18.7
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
Share & Embed Analysis
Last updated: May 18, 2026 4:06 AM ET
Data refreshes hourly during market hours. Next update: 5:06 AM
Data refreshes hourly during market hours. Next update: 5:06 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is PRVA showing a specific setup today?
Insider Activity (6 Months)
0
Buys
20
Sells
Net
INSIDERS SELLING
Recent Transactions
David Mountcastle
SELL
5566 shares
2026-04-02
David Mountcastle
SELL
6391 shares
2026-03-16
Parth Mehrotra
SELL
26509 shares
2026-03-16
Top Rated Health Information Services Stocks
Top-rated stocks in Health Information Services by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
VEEV
Veeva Systems Inc Class A |
BUY
32 analysts |
$264 | 55 HOLD |
|
GEHC
GE HealthCare Technologi… |
STRONG BUY
21 analysts |
$90 | 58 HOLD |
|
PHR
Phreesia Inc |
STRONG BUY
15 analysts |
$15 | 52 HOLD |
|
EVH
Evolent Health Inc |
STRONG BUY
14 analysts |
$6 | 60 HOLD |
|
HQY
HealthEquity Inc |
STRONG BUY
14 analysts |
$113 | 56 HOLD |
Advanced PRVA Option Strategies
Professional options setups generated by AI based on today's PRVA price and gamma walls.
